Latest News
Failing to recognize this critical difference between retirement and spousal benefits could cost you a lot of money.
Via The Motley Fool · September 11, 2026
Lam Research (NASDAQ:LRCX) said it is prioritizing customer execution, capacity readiness and product-roadmap delivery as semiconductor equipment demand remains strong and customers seek tools sooner than the company can provide them.
During a Goldman Sachs discussion with Senior Equity Analyst Jim
Via MarketBeat · September 11, 2026
Cheetah Mobile (NYSE:CMCM) said its second-quarter 2026 results reflected a continued shift toward cloud and AI infrastructure services and robotics, even as changes affecting its advertising agency business weighed on profitability.
Total revenue was RMB266.1 million, up 2.7% from the prior quarte
Via MarketBeat · September 11, 2026
Big issues are being decided in September, but that might not justify a rushed investment.
Via The Motley Fool · September 11, 2026
Zumiez missed earnings estimates and guided lower. The culprit may surprise you.
Via The Motley Fool · September 11, 2026
Amgen is profitable and paying a growing dividend, while Revolution Medicines is burning cash to fund what could be one of the most important cancer drug launches in years.
Via The Motley Fool · September 11, 2026
This Canadian stock has a proven record of paying dividends and consistently raising their payouts in the years ahead.
Via The Motley Fool · September 11, 2026
Wednesday's 319 million-share release leaves billions more on the unlock calendar.
Via The Motley Fool · September 11, 2026
Oracle's fiscal Q1 revenue grew nearly 30% with a record $23 billion cash flow and surging backlog, as analysts cite an AI monetization inflection point supporting a Moderate Buy consensus.
Via MarketBeat · September 11, 2026
One company is generating billions in revenue and raising its dividend. The other is burning cash in pursuit of a scientific breakthrough that could change how diseases are treated.
Via The Motley Fool · September 11, 2026
Don't put all of your eggs in one basket.
Via The Motley Fool · September 11, 2026
Meta stock gains over 1% as the tech giant explores European bond markets to fund AI infrastructure growth. Learn more.
Via Benzinga · September 11, 2026
AMD's data center momentum clashes with Qualcomm's valuation discount, but customer concentration and geopolitical risks complicate both bets.
Via The Motley Fool · September 11, 2026
Broadcom's custom AI chips are becoming more popular with AI hyperscalers.
Via The Motley Fool · September 11, 2026
National Beverage stock has lots of problems right now, and no good solutions.
Via The Motley Fool · September 11, 2026
CleanSpark (CLSK) stock jumped 8%+ as Bitcoin rebounded to $79K. Read key technical levels, operational updates, and ETF insights.
Via Benzinga · September 11, 2026
Bitcoin reclaims $80,000 as Bitwise forecasts a strong Q4 2026, fueled by ETF inflows, institutional demand and rotation from equities.
Via Benzinga · September 11, 2026
Via MarketBeat · September 11, 2026
Eli Lilly is expanding into women's health, targeting endometriosis and pregnancy disorders by hiring experts and strategic investments.
Via Benzinga · September 11, 2026
TSMC reported August 2026 revenue up 53.3% year over year, with strong margins, insider buying, and analysts maintaining a consensus Buy rating and $523.22 average price target.
Via MarketBeat · September 11, 2026
Copart acquires ACV, merging digital inspection with physical logistics amid volume declines.
Via The Motley Fool · September 11, 2026
Oracle's AI RPO surged, fueled mostly by prepaid and customer-funded hardware deals, according to management's commentary.
Via Benzinga · September 11, 2026
One company is scaling revenue rapidly but burning cash; the other is pioneering gene therapy with minimal sales and massive losses.
Via The Motley Fool · September 11, 2026
Robotaxis could become a $10 trillion global industry.
Via The Motley Fool · September 11, 2026
